Psychemedics Corporation (PMD)

NASDAQ: PMD · IEX Real-Time Price · USD
5.74
+0.02 (0.26%)
At close: Dec 2, 2022 4:00 PM
5.45
-0.29 (-4.97%)
After-hours: Dec 2, 2022 4:35 PM EST
0.26%
Market Cap 32.29M
Revenue (ttm) 25.97M
Net Income (ttm) -2.02M
Shares Out 5.63M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend $0.26 (4.53%)
Ex-Dividend Date Dec 1, 2022
Volume 3,455
Open 5.76
Previous Close 5.72
Day's Range 5.72 - 5.76
52-Week Range 5.61 - 8
Beta 0.55
Analysts n/a
Price Target n/a
Earnings Date Nov 11, 2022

About PMD

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium... [Read more]

Industry Health Care Providers & Services
Founded 1986
Employees 139
Stock Exchange NASDAQ
Ticker Symbol PMD
Full Company Profile

Financial Performance

In 2021, Psychemedics's revenue was $24.91 million, an increase of 16.62% compared to the previous year's $21.36 million. Losses were -$665,000, -82.77% less than in 2020.

Financial Statements

News

Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third q...

3 weeks ago - GlobeNewsWire

Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second ...

3 months ago - GlobeNewsWire

Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. T...

ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Board ...

5 months ago - GlobeNewsWire

Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first qu...

6 months ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year fin...

8 months ago - GlobeNewsWire

Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Conni...

ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M. Reynolds t...

8 months ago - GlobeNewsWire

Psychemedics Corporation Declares Cash Dividend

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced that it has declared a cash divide...

11 months ago - GlobeNewsWire

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third qu...

1 year ago - GlobeNewsWire

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second q...

1 year ago - GlobeNewsWire

5 Undervalued Stocks Trading Below the Peter Lynch Value

According to the GuruFocus All-in-One Screener, a Premium feature, as of June 28, the following companies are trading below their Peter Lynch fair values with wide margins of safety and have had positiv...

Other symbols: BDNGPINNITPH
1 year ago - GuruFocus

Montana Advisors Writes Open Letter to Psychemedics

MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time y...

1 year ago - Business Wire

Psychemedics Corporation Reports First Quarter 2021 Financial Results

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first qua...

1 year ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results

ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year fina...

1 year ago - GlobeNewsWire

Robyn C. Davis Joins Psychemedics Board of Directors

ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporati...

1 year ago - GlobeNewsWire

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.

1 year ago - GlobeNewsWire

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel.

1 year ago - GlobeNewsWire

Psychemedics Announces Third Quarter Results

ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.

2 years ago - GlobeNewsWire

Psychemedics Announces Second Quarter Results

ACTON, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020. 

2 years ago - GlobeNewsWire

Psychemedics Announces First Quarter Results

ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. 

2 years ago - GlobeNewsWire

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

A New and Cost-Effective Tool to Detect and Deter Nicotine use A New and Cost-Effective Tool to Detect and Deter Nicotine use

2 years ago - GlobeNewsWire

Top Marijuana Stocks on the NASDAQ

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

2 years ago - Investopedia

Psychemedics Corporation Responds to Court Decision

ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v...

3 years ago - GlobeNewsWire

Psychemedics Corporation Announces New Brazilian Distribution Agreement

ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with...

3 years ago - GlobeNewsWire